Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on July 21, 2008

Circulation. 2008
Published online before print July 21, 2008, doi: 10.1161/CIRCULATIONAHA.107.761064
A more recent version of this article appeared on August 5, 2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
118/6/667    most recent
CIRCULATIONAHA.107.761064v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Imazio, M.
Right arrow Articles by Trinchero, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Imazio, M.
Right arrow Articles by Trinchero, R.
Related Collections
Right arrow Pericardial disease
Right arrow Cardiovascular Pharmacology
Right arrowRelated Article

Submitted on December 18, 2007
Accepted on May 30, 2008

Corticosteroids for Recurrent Pericarditis. High Versus Low Doses: A Nonrandomized Observation

Massimo Imazio MD*, Antonio Brucato MD, Davide Cumetti MD, Giovanni Brambilla MD, Brunella Demichelis MD, Silvia Ferro MD, Silvia Maestroni MD, Enrico Cecchi MD, Riccardo Belli MD, Giancarlo Palmieri MD, and Rita Trinchero MD

From the Cardiology Department, Ospedale Maria Vittoria, Torino (M.I., B.D., S.F., E.C., R.B., R.T.); Department of Internal Medicine, Ospedali Riuniti, Bergamo (A.B., D.C., S.M.); and Department of Emergency Medicine, and Internal Medicine, Ospedale Niguarda, Milan (G.B., G.P.), Italy.

* To whom correspondence should be addressed. E-mail: massimo_imazio{at}yahoo.it.

Background—Corticosteroid use is widespread in recurrent pericarditis, even if rarely indicated, and high doses (eg, prednisone 1.0 to 1.5 mg · kg-1 · d-1) are generally recommended, although only weak evidence supports their use with possible severe side effects. The aim of this work was to compare side effects, recurrences and other complications, and hospitalizations of a low- versus high-dose regimen of prednisone for recurrent pericarditis.

Methods and Results—A retrospective review of all cases of recurrent pericarditis treated with corticosteroids according to different regimens from January 1996 to June 2004 was performed in 2 Italian referral centers. One hundred patients with recurrent pericarditis (mean age, 50.1±15.8 years; 57 females) were included in the study; 49 patients (mean age, 47.5±16.0; 25 females) were treated with low doses of prednisone (0.2 to 0.5 mg · kg-1 · d-1), and 51 patients (mean age, 52.6±15.3; 32 females) were treated with prednisone 1.0 mg · kg-1 · d-1. Baseline demographic and clinical characteristics were well balanced across the groups. Each initial dose was maintained for 4 weeks and then slowly tapered. After adjustment for potential confounders (age, female gender, nonidiopathic origin), only high doses of prednisone were associated with severe side effects, recurrences, and hospitalizations (hazard ratio, 3.61; 95% confidence interval, 1.96 to 6.63; P<0.001).

Conclusions—Use of higher doses of prednisone (1.0 mg · kg-1 · d-1) for recurrent pericarditis is associated with more side effects, recurrences, and hospitalizations. Lower doses of prednisone should be considered when corticosteroids are needed to treat pericarditis.


Key words: corticosteroids • pericarditis • pericardium • therapy


Related Article:

Clinical Summaries
Circulation 2008 118: 607-608. [Extract] [Full Text]



This article has been cited by other articles:


Home page
ESC Textbook of Cardiovascular MedicineHome page
J. Soler-Soler and J. Sagristà-Sauleda
CHAPTER 19 Pericardial Disease
ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Shabetai
Corticosteroids for Recurrent Pericarditis: On the Road to Evidence-Based Medicine
Circulation, August 5, 2008; 118(6): 612 - 613.
[Full Text] [PDF]